NasdaqGS:ICUI

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. More Details


Snowflake Analysis

Excellent balance sheet with proven track record.


Similar Companies

Share Price & News

How has ICU Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ICUI has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-7.6%

ICUI

-3.3%

US Medical Equipment

-3.3%

US Market


1 Year Return

17.3%

ICUI

13.7%

US Medical Equipment

10.9%

US Market

Return vs Industry: ICUI exceeded the US Medical Equipment industry which returned 13.7% over the past year.

Return vs Market: ICUI exceeded the US Market which returned 10.9% over the past year.


Shareholder returns

ICUIIndustryMarket
7 Day-7.6%-3.3%-3.3%
30 Day-4.2%-2.5%-5.7%
90 Day6.5%12.2%8.2%
1 Year17.3%17.3%14.7%13.7%13.4%10.9%
3 Year-1.3%-1.3%69.0%64.7%34.9%25.9%
5 Year68.2%68.2%140.9%122.6%84.6%63.8%

Price Volatility Vs. Market

How volatile is ICU Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is ICU Medical undervalued compared to its fair value and its price relative to the market?

45.91x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: ICUI ($183.45) is trading above our estimate of fair value ($93.59)

Significantly Below Fair Value: ICUI is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ICUI is good value based on its PE Ratio (45.9x) compared to the US Medical Equipment industry average (48.8x).

PE vs Market: ICUI is poor value based on its PE Ratio (45.9x) compared to the US market (17.4x).


Price to Earnings Growth Ratio

PEG Ratio: ICUI is poor value based on its PEG Ratio (5.2x)


Price to Book Ratio

PB vs Industry: ICUI is good value based on its PB Ratio (2.7x) compared to the US Medical Equipment industry average (3.7x).


Next Steps

Future Growth

How is ICU Medical forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

8.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ICUI's forecast earnings growth (8.8% per year) is above the savings rate (2.2%).

Earnings vs Market: ICUI's earnings (8.8% per year) are forecast to grow slower than the US market (23% per year).

High Growth Earnings: ICUI's earnings are forecast to grow, but not significantly.

Revenue vs Market: ICUI's revenue (2.5% per year) is forecast to grow slower than the US market (9.9% per year).

High Growth Revenue: ICUI's revenue (2.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ICUI's Return on Equity is forecast to be low in 3 years time (7.3%).


Next Steps

Past Performance

How has ICU Medical performed over the past 5 years?

10.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ICUI has a large one-off loss of $58.7M impacting its June 30 2020 financial results.

Growing Profit Margin: ICUI's current net profit margins (6.6%) are higher than last year (3.6%).


Past Earnings Growth Analysis

Earnings Trend: ICUI's earnings have grown by 10.4% per year over the past 5 years.

Accelerating Growth: ICUI's earnings growth over the past year (76.6%) exceeds its 5-year average (10.4% per year).

Earnings vs Industry: ICUI earnings growth over the past year (76.6%) exceeded the Medical Equipment industry 1.8%.


Return on Equity

High ROE: ICUI's Return on Equity (5.9%) is considered low.


Next Steps

Financial Health

How is ICU Medical's financial position?


Financial Position Analysis

Short Term Liabilities: ICUI's short term assets ($1.0B) exceed its short term liabilities ($359.2M).

Long Term Liabilities: ICUI's short term assets ($1.0B) exceed its long term liabilities ($88.1M).


Debt to Equity History and Analysis

Debt Level: ICUI's debt to equity ratio (10.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if ICUI's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: ICUI's debt is well covered by operating cash flow (112.3%).

Interest Coverage: ICUI earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is ICU Medical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ICUI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ICUI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ICUI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ICUI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ICUI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.7yrs

Average management tenure


CEO

Vivek Jain (48 yo)

6.58yrs

Tenure

US$2,825,277

Compensation

Mr. Vivek Jain serves as an Independent Director at Envista Holdings Corporation since April 7, 2020. He has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr. Jain ...


CEO Compensation Analysis

Compensation vs Market: Vivek's total compensation ($USD2.83M) is below average for companies of similar size in the US market ($USD5.75M).

Compensation vs Earnings: Vivek's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Vivek Jain
CEO & Chairman of the Board6.58yrsUS$2.83m0.32%
$ 12.1m
Christian Voigtlander
Chief Operating Officer2.67yrsUS$2.50m0.037%
$ 1.4m
Virginia Sanzone
Corporate VP2.67yrsUS$1.40m0.0072%
$ 274.6k
Daniel Woolson
Corporate VP & GM of Infusion Systems3.58yrsUS$1.40m0.029%
$ 1.1m
Brian Bonnell
CFO & Treasurer0.50yrno data0.0044%
$ 168.2k
Kevin McGrody
Chief Accounting Officerno datano data0.011%
$ 427.5k
Steven Riggs
Executive Officer of Special Project Opertionsno dataUS$1.05mno data

2.7yrs

Average Tenure

47yo

Average Age

Experienced Management: ICUI's management team is considered experienced (2.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Vivek Jain
CEO & Chairman of the Board6.58yrsUS$2.83m0.32%
$ 12.1m
Elisha Finney
Independent Director4.67yrsUS$267.01k0.0071%
$ 271.9k
George Lopez
Director36.67yrsUS$368.40k5.86%
$ 225.1m
Robert Swinney
Independent Director22.67yrsUS$257.51k0.11%
$ 4.1m
David Hoffmeister
Independent Director2.67yrsUS$240.01k0.0033%
$ 127.1k
David Greenberg
Lead Independent Directorno dataUS$278.51k0.015%
$ 587.7k
Donald Abbey
Independent Director2.67yrsUS$240.01k0.0033%
$ 127.1k

5.6yrs

Average Tenure

59yo

Average Age

Experienced Board: ICUI's board of directors are considered experienced (5.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ICUI insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

ICU Medical, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ICU Medical, Inc.
  • Ticker: ICUI
  • Exchange: NasdaqGS
  • Founded: 1984
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$3.841b
  • Shares outstanding: 20.94m
  • Website: https://www.icumed.com

Number of Employees


Location

  • ICU Medical, Inc.
  • 951 Calle Amanecer
  • San Clemente
  • California
  • 92673
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ICUINasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDMar 1992
IC7DB (Deutsche Boerse AG)YesCommon StockDEEURMar 1992

Biography

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company’s infusion therapy produc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/25 05:51
End of Day Share Price2020/09/24 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.